SEP 05, 2018 8:23 AM PDT

Can AI Algorithms Accurately Assess Mental Illness?

Mental illness is complicated because while the causes are rooted in brain chemistry, neurological injury or other mechanisms in the brain, what is most affected are the daily lives of patients and their families.

Living with mental disorders like major depressive disorder or bipolar disorder is difficult, especially since many patients do not find relief in medications. Talk therapy and cognitive behavioral therapy (CBT) are other ways to treat mental illness; however it’s very much a trial and error process that can be time-consuming and frustrating.

Researchers from Lawson Health Research Institute, The Mind Research Network, and Brainnetome Center, collaborated recently on a study that shows how artificial intelligence (AI) and a precisely created algorithm that can analyze brain scans. The technology is aimed at better classifying diagnoses in patients and helping to predict what the patient’s response to specific medications might be, based on their particular illness characteristics.

The study cohort included 78 adult patients from mental health programs at London Health Sciences Centre (LHSC) and who were mostly from the First Episode Mood and Anxiety Program (FEMAP.) The study began with 66 patients who had completed treatment for a definite diagnosis of either major depressive disorder (MDD) or bipolar type I. Type I bipolar disorder is a form of the disease that includes full manic episodes as well as depressive episodes. There were also an additional 33 healthy patients, with no history of mental illness, as a control group. All of the participants underwent functional MRI (fMRI) scans as part of the research.

The research team analyzed the scans from each group and found, not surprisingly, that there were distinct differences in brain networks including the default mode network which regulates self-reflection, and the thalamus which is a connector hub that links multiple cortical regions and is involved in arousal and alertness. This data was the basis for an AI algorithm that used machine learning to pinpoint whether a patient had MDD or bipolar I When the AI program was tested to see if it could accurately diagnose the correct disorder based on the scans, it scored an impressive 92.4% for accuracy.

The research team then took it up a notch and had the AI algorithm look at brain scans from a dozen other patients who had did not have a precise diagnosis due to overlapping symptoms and other factors. Patients with MDD will often respond well to antidepressants, while patients who have bipolar I will do better on mood stabilizing drugs. The AI algorithm correctly predicted which disorders were present and which class of medications would have the best patient response in 11 of the 12 difficult cases.

Dr. Elizabeth Osuch, a clinician-scientist at Lawson, medical director at FEMAP and co-lead investigator on the study, explained, Antidepressants are the gold standard pharmaceutical therapy for MDD while mood stabilizers are the gold standard for bipolar I. But it becomes difficult to predict which medication will work in patients with complex mood disorders when a diagnosis is not definite. Will they respond better to an antidepressant or to a mood stabilizer? This study takes a major step towards finding a biomarker of medication response in emerging adults with complex mood disorders,” says Dr. Osuch. “It also suggests that we may one day have an objective measure of psychiatric illness through brain imaging that would make diagnosis faster, more effective and more consistent across health care providers.”

The video below features Dr. Osuch as well as more information on the research, take a look.

Sources: R&D Mag, Lawson Research, Acta Pyschiatrica Scandanavica

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JAN 29, 2020
Health & Medicine
JAN 29, 2020
Feeling Bloated? A High-Fiber, Protein-Rich Diet May be to Blame
Did your new year’s resolution include opting for a healthier diet? When making changes to your diet, it’s important to be aware of possible si...
FEB 05, 2020
Cardiology
FEB 05, 2020
Protein-Rich Foods May Damage Heart Health
High-protein diets are becoming more and more popular as a method to both increase muscle mass and lose weight. Now however, new research is showing that e...
FEB 05, 2020
Cannabis Sciences
FEB 05, 2020
Should You Be Using Marijuana While Pregnant? Researchers Weigh In
Recreational marijuana use becomes increasingly common as legalization spreads across the country. That includes women who are pregnant and women in the mo...
FEB 17, 2020
Immunology
FEB 17, 2020
Another HIV vaccine attempt fizzles out
Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals ag...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Why is it so Difficult to Develop a Vaccine for Coronavirus?
As of February 21st, 2,250 have died worldwide from Coronavirus, while 18,862 have recovered and 55,703 are currently infected. Having made top news storie...
FEB 11, 2020
Neuroscience
FEB 11, 2020
Soybean oil Causes Genetic Changes in Mouse Brain
Source: Hypothalmus and limic system   Soybean oil is used for cooking fast food, in packaged products, and to feed livestock, making it the most wide...
Loading Comments...